-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
According to the previous schedule, the results of the sixth batch of special centralized procurement of national insulin will be implemented in May 202 At present, the first-year agreement procurement volume in various regions across the country has been determin.
May 1: Tianjin, Tibet
May 6: Fujian
May 15: Liaoning, Gansu
May 20: Heilongjiang, Qinghai, Ningxia, Shanxi, Inner Mongolia, Hebei
May 25: Jiangxi
May 26: Shandong
May 27: Sichuan
May 30: Hainan, Guizhou, Shaanxi, Zhejiang, Henan, Guangxi
24:00 on May 31: Jiangsu
On May 18, the Hunan Provincial Medical Insurance Bureau issued the "Notice on Doing a Good Job in Preparing for the Implementation of the Selected Results of Centralized Drug Purchasing (Insulin Special) Organized by the State", which clarified that the nationally selected varieties should be declared and listed at the selected price, and pre-filled, special The price of refillable and smooth-filled insulin products can be increased by 3 yuan each on the basis of the selected price of the same type of refill insulin products of the same compa.
Many provinces have clarified the landing time of the sixth batch of national procurement (special centralized insulin procurement)
Many provinces have clarified the landing time of the sixth batch of national procurement (special centralized insulin procurement)On November 30, 2021, the results of the national selection of insulin were officially announc.
On April 29, the National Medical Insurance Administration and the National Health and Health Commission jointly issued the "Notice on Improving the Supporting Measures for the Centralized Procurement and Use of Nationally-Organized Drugs (Insulin Special.
The "Notice" requires online purchases at the selected pri.
According to the previous schedule, it is expected that the results of the selection will be officially implemented in M.
In addition, some provinces have also made clear regulations on the online and medical insurance payment standards for unselected varieti.
Fujian:
On April 14, Fujian issued the "Notice on the Implementation of the Sixth Batch of State-Organized Centralized Procurement of Drugs (Insulin Special) and Use of Related Wor.
The medical insurance payment standard for drugs in the competition group is determined by not exceeding the lowest selected price of the same generic name and the same group; the medical insurance payment standard for the non-competitive group drugs is temporarily determined at 70% of the sales price, and is based on the lowest selected price of the same generic name and the same gro.
Hainan:
On April 25, the Hainan Provincial Medical Security Bureau issued the "Notice on Doing a Good Job in the Implementation of the Results of the Sixth Batch of Centralized Drug Procurement (Insulin Special) Organized by the State", which clarified that the price of the selected drugs should be used as the payment standard, and the non-selected drugs should be pa.
Tianjin:
On April 28, Tianjin issued the "Notice on Implementing the Sixth Batch of Centralized Procurement and Use of State-Organized Drugs", which clarified that non-selected products that meet the conditions for centralized procurement will be listed on the Internet at a price not higher than the supply price of this variety in other parts of the count.
Qinghai:
On May 12, the Qinghai Municipal Medical Insurance Bureau issued the "Notice on Implementing the Results of the Sixth Batch of Nationally Organized Centralized Drug Purchasing (Insulin Special)", clarifying that medical institutions can ensure the completion of the annual agreement purchase amount while combining clinical u.
The purchase price of non-selected drugs shall not be higher than the listed price declared by the enterprise, and zero-markup sales shall be implement.
Heilongjiang:
On May 13, the Heilongjiang Provincial Medical Insurance Bureau issued the "Notice on Doing a Good Job in the Implementation of the Sixth Batch of Nationally Organized Drug Collection (Insulin Special)", which clarified that if the non-selected insulin products belong to the medical insurance fund payment scope, the payment standard does not exceed the same amou.
Ningxia:
On May 5, Ningxia issued the "Notice on Doing a Good Job in the Implementation of the Selected Results of the Sixth Batch of National Centralized Drug Procurement (Insulin Special)",Non-selected products should be based on the principle of efficacy and price matching, and fully consider the selected produc.
The selected products of insulin centralized procurement shall be paid based on the selected online price, and the medical insurance fund shall pay according to the prescribed proporti.
Shanxi:
On May 7, Shanxi issued the "Notice on Fully Implementing the Results of the Sixth Batch of Nationally Organized Centralized Drug Procurement (Insulin Special)", clarifying that non-selected insulin products fall within the scope of payment by the medical insurance fund, and the payment standard does not exceed the selected products of the same catego.
The highest selected price or the negotiated price of medical insurance, the patient uses non-selected products, and the part of the price exceeding the payment standard of medical insurance shall be paid by the patie.
Shaanxi:
On May 10, Shaanxi issued the "Notice on Doing a Good Job in the Centralized Procurement and Use of the Sixth Batch of Drugs (Insulin Special) Organized by the Stat.
If the listed price is implemented within 1 month, the adjustment should be reported to the provincial pharmaceutical equipment procurement platform), and relevant enterprises are encouraged to adjust the price to a reasonable lev.
If the non-selected insulin products are covered by the medical insurance fund, the payment standard shall not exceed the highest selected price of the selected products in the same category or the negotiated price of medical insuran.
If the patient uses the non-selected product, the part of the price exceeding the medical insurance payment standard shall be paid by the patie.
Inner Mongolia:
On May 13, Inner Mongolia issued the "Notice on Doing a Good Job in the Centralized Procurement and Use of Nationally Organized Drugs (Insulin Special.
If the non-selected insulin products belong to the scope of payment of the medical insurance fund, the payment standard shall not exceed the selected products of the same catego.
The highest selected price or the negotiated price of medical insurance, the patient uses non-selected products, and the part of the price exceeding the payment standard of medical insurance shall be paid by the patie.
In addition, in accordance with the principle of matching efficacy and price, fully consider the reasonable price comparison with the selected products, carry out gradient price reductions for non-selected products, and guide and encourage relevant enterprises to adjust prices to a reasonable lev.
Henan
On May 13, Henan issued the "Notice on Doing a Good Job in the Implementation of the Selected Results of the Sixth Batch of Nationally Organized Centralized Drug Procurement (Insulin Special) and Other Four Batches of Centralized Drug Procurement", clarifying that the non-selected insulin products belong to the scope of payment by the medical insurance fu.
, the payment standard does not exceed the highest selected price of the selected products in the same category or the negotiated price of medical insuran.
If the patient uses non-selected products, the part of the price that exceeds the medical insurance payment standard shall be paid by the patie.
Guangxi
On May 16, Guangxi issued the "Notice on Doing a Good Job in the Centralized Procurement and Use of the Sixth Batch of Nationally Organized Drugs (Special Insulin)", which clarified that if the non-selected insulin products fall within the scope of payment of the medical insurance fund, the original research under the same generic name will be treat.
The same medical insurance payment standard applies to medicines, reference preparations, and generic drugs that have passed the consistency evaluati.
For generic drugs that have not passed the consistency evaluation, the medical insurance payment standard shall not be higher than the drugs under the same generic name that have passed the consistency evaluati.
Patients use non-selected products, and the part of the price that exceeds the medical insurance payment standard shall be paid by the patie.
Jiangsu
On May 16, Jiangsu issued the "Notice on Doing a Good Job in the Implementation of the Results of the Sixth Batch of Nationally Organized Centralized Drug Procurement (Insulin Special)", which clarified that if the non-selected insulin products belong to the scope of payment of the medical insurance fund, the payment standard shall not exceed that of the selected ones in the same catego.
The highest selected price of the product; the medical insurance fund is paid according to the prescribed proportion, and the payment standard is uniformly implemented in the whole provin.
Patients use non-selected products, and the part of the price exceeding the medical insurance payment standard shall be paid by the patient, which is included in the statistical caliber within the scope of the poli.
